31 COVID-19 Update Week of August 9, 2021 - Prepared by: Toni P. Brown Chief Administrative Officer Delaware River Port Authority August 9, 2021 ...

COVID-19 Update Week of August 9, 2021
Prepared by: Toni P. Brown
Chief Administrative Officer
Delaware River Port Authority
August 9, 2021 – Special Update
                                         31

2

3

B.1.617.2 (Delta) Variant

    The highly transmissible B.1.617.2 (Delta) variant continues to spread
    across the United States at a rapid pace.

    Early data suggest that B.1.617.2 now makes up more than 94% of COVID-
    19 cases. In some parts of the country, this percentage is even higher,
    especially in areas with low vaccination rates.

    This rapid rise is concerning and threatens the progress the United States
    has made toward ending the pandemic.

    VIDEO: Delta variant: Why the respiratory illness is so easily transmissible

    Severe Dangers of Delta Variant, Even for the Vaccinated

    Fact check: What do we know about the coronavirus delta variant?

    3 Things You Need to Know About the Delta Variant
4

B.1.617.2 (Delta) Variant

    •   CDC Director Dr. Rochelle Walensky Shares What to Know about Delta
        Variant

    •   NPR: Delta is surging. Here's what you need to know to stay safe.

    •   How Delta variant is pushing the U.S. into a new phase of the COVID-19
        pandemic

    •   Internal CDC document warns delta infections likely more severe than
        earlier variants and spreads as easily as chickenpox; urges new
        messaging

    •   NPR 3-Minute Listen: A CDC document gives new details on just how
        dangerous the Delta variant really is - More contagious, increased risk of
        severe disease and hospitalization, compared with original strain

5

COVID-19 Virus Tracker
Infections and Deaths

203 million
    Confirmed COVID-19 Cases Worldwide

    4.29 million
    COVID-19-Related Deaths Worldwide

    2.11%
    Rate of COVID-19-Related Deaths Worldwide
7
                            Data is approximate as of 8/8/2021

35.8 million
    Confirmed COVID-19 Cases in the U.S.

    616,000
    COVID-19-Related Deaths in the U.S.

    1.72%
    Rate of COVID-19-Related Deaths in the U.S.
8                                     Data is approximate as of 8/8/2021

1.05 million
    Confirmed COVID-19 Cases in the NJ

    26,645
    COVID-19-Related Deaths in the NJ

    2.53%
    Rate of COVID-19-Related Deaths in the NJ
9                                    Data is approximate as of 8/8/2021

1.24 million
     Confirmed COVID-19 Cases in the PA

     27,902
     COVID-19-Related Deaths in the PA

     2.25%
     Rate of COVID-19-Related Deaths in the PA
10                                        Data is approximate as of 8/8/2021

Vaccines
Status of
EUAs Granted

COVID-19 Vaccines Granted
     Emergency Use Authorization (EUA) by
     U.S. Food and Drug Administration (FDA)

      ▸   United States of America
          ▹   EUA granted 12/11/2020

               ■    Pfizer-BioNTech

               ■    16 years and older

               ■    FDA authorizes vaccine for adolescents 12-15 years old

               ■    mRNA vaccine

          ▹   EUA granted 12/17/2020

               ■    Moderna (in partnership with NIAID)

               ■    18 years and older

12
               ■    mRNA vaccine

Emergency Use Authorization (EUA)
     by FDA

       ▸   United States of America
           ▹   EUA granted 2/27/2021
                ■   Janssen (Johnson & Johnson)
                ■   18 years and older
                ■   Adenoviral vector vaccine READ: NYTimes - An excellent primer on
                    adenovirus vector vaccines
                ■   FORBES: Everything You Need To Know About Johnson & Johnson’s
                    COVID-19 Vaccine

13

Oxford-AstraZeneca’s Vaccine
     Status: In the Pipeline

       ▸   Oxford University and AstraZeneca (AZD1222)
           ▹   A Viral Vector Vaccine, similar to the Johnson & Johnson vaccine
           ▹   The AstraZeneca COVID-19 vaccine is now called Vaxzevira
           ▹   A specially engineered virus delivers genetic instructions to human cells to make the
               spike protein jutting out from the new coronavirus’s surface.
           ▹   AstraZeneca pledged the vaccine would cost just a few dollars per dose and be sold
               without making a profit. ($4.00 per dose)
           ▹   Compare to Pfizer’s vaccine costs per dose: $18.40 - $19.50.

14

Oxford-AstraZeneca’s Vaccine
     Status: In the Pipeline

       ▸   Oxford University and AstraZeneca (AZD1222)
           ▹   Data from clinical trial in the United States, Chile and Peru
                ■     Trials included 32,449 adult participants in all age groups, most of them in the
                      United States
                ■     The volunteers received two standard doses of the Oxford-AstraZeneca vaccine,
                      or a placebo, at a four-week interval
                ■     Scientists said the data shows that the vaccine is 79% effective against
                      symptomatic COVID-19, and 100% effective against severe illness
                ■     STAT - June 14, 2021: Novavax COVID-19 vaccine highly effective in late-stage
                      trial, long awaited results show

15

Oxford-AstraZeneca’s Vaccine
     Status: In the Pipeline

       ▸   Oxford University and AstraZeneca (AZD1222)
           ▹   In March 2021, several European countries paused the use of the AstraZeneca COVID-
               19 vaccine after several reports of blood clots.
           ▹   The clots that are linked to the vaccine have very specific characteristics:
                ■     They occur in unusual areas of the body, like the abdomen or brain.
                ■     People affected also have low platelet levels.
                ■     It was found that people with these blood clots showed symptoms like a
                      condition called heparin-induced thrombocytopenia (HIT).
                ■     Researchers are not sure what parts of the vaccine is causing an immune
                      response. For more information: What you should know about the
                      AstraZeneca COVID-19 vaccine
16

Demographic Data
 Progress to Date - as of August 8, 2021

Approximately 50.1% of the total U.S. population– or 166,477,481 million people --
is now fully vaccinated. Today, about 58.7% of the population (about 194,866,738
million) have had at least one dose. (Source: CDC)

Vaccine Tracker – New Jersey
     As of August 8, 2021 - Based on Data from the Centers for Disease Control and Prevention

       Overall US COVID-19 Vaccine Distribution and Administration

       • Residents who are fully vaccinated:
          • New Jersey – 5,190,166
              • Asian 11%; Black 8%; Latinx 16%; White 48%; Unknown 9%;
                           Other 9%
                     • Female 53%; Male 47%
                     • Jansen (J&J) 4%; Moderna 40%; Pfizer 47%
18

Vaccine Tracker – New Jersey
     As of August 8, 2021 - Based on Data from the Centers for Disease Control and Prevention

       Overall US COVID-19 Vaccine Distribution and Administration

       • Residents who are partially vaccinated:
          • New Jersey – 5,828,767

19

Vaccine Tracker – Pennsylvania
     As of August 8, 2021 - Based on Data from the Centers for Disease Control and Prevention

       Overall US COVID-19 Vaccine Distribution and Administration

       • Residents who are fully vaccinated:
          • Pennsylvania – 5,760,327
          • Partial vaccinations – 5,986,469
          • Total vaccinations – 11,746,796

20

Links to Additional Articles

     ▪   If you're not protected against Covid-19, the virus 'will find you, it will infect you,' expert says – CNN

     ▪   US coronavirus: Young children will pay the price if enough US adults don't get vaccinated against Covid-19,
         expert says – CNN

     ▪   Why a Covid-19 vaccine isn't available for kids yet – CNN

     ▪   NPR: Serious cases remain rare, but Coronavirus infections in children are on the rise

     ▪   NPR: World Health Organization is calling for a moratorium on COVID vaccine boosters until more people
         around the world get their first doses. But the White House is pushing back, saying if U.S. health officials call
         for booster shots, they'll provide those to Americans - while also shipping hundred of millions of vaccines to
         other countries

     ▪   Kids and the COVID-19 Delta variant: Top doctors answer what we need to know

     ▪   CHART: COVID-19, Influenza, and RSV Similarities & Differences

22

Links to Additional Articles

     ▪   On August 6, 2021, Gov. Murphy signed Executive Order (EO) 251, which will mandate masking in the
         indoor premises of all public, private, and parochial preschool, elementary, and secondary school
         buildings. The Executive Order is effective on Monday, August 9, 2021. Executive Order No. 251

     ▪   Press Release: Gov. Murphy Announces Indoor Mask Requirement for Beginning of 2021-2022
         School Year

     ▪   Gov. Murphy announces NJ school mask mandate. Here's what you need to know

     ▪   FINAL EXTENSION OFFERED To BORROWERS: Biden administration extends pause on federal
         student loan payments through January 31, 2022. Moratorium was set to expire on September 30.

     ▪   Should I Mask? Can I Travel? What About Hugs? How Delta Is Changing Advice for the Vaccinated

     ▪   Press Release: Gov. Murphy Announces Vaccine Requirement for Workers in Health Care Facilities
         and High Risk Congregate Settings

23

You can find me at
     tpbrown@drpa.org

24